SNY - AstraZeneca Settles Heartburn Treatment Lawsuit For One Of Biggest Selling Drug | Benzinga
AstraZeneca Plc (NASDAQ: AZN) has agreed to pay $425 million to settle U.S. lawsuits related to heartburn and stomach acid treatments Nexium and Prilosec.
The heartburn treatments have been under litigation, as some users said they caused kidney damage.
Several lawsuits have been filed in California against GSK Plc (NYSE: GSK), Sanofi SA (NASDAQ: SNY), Pfizer ...